Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study

Background. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significan...

Full description

Bibliographic Details
Main Authors: Maria do Sameiro-Faria, Sandra Ribeiro, Elísio Costa, Denisa Mendonça, Laetitia Teixeira, Petronila Rocha-Pereira, João Fernandes, Henrique Nascimento, Michaela Kohlova, Flávio Reis, Leonilde Amado, Elsa Bronze-da-Rocha, Vasco Miranda, Alexandre Quintanilha, Luís Belo, Alice Santos-Silva
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2013/518945
id doaj-0ec9bbfccd104cc8a74bc8e1a48e04c6
record_format Article
spelling doaj-0ec9bbfccd104cc8a74bc8e1a48e04c62020-11-24T23:18:41ZengHindawi LimitedDisease Markers0278-02401875-86302013-01-0135679179810.1155/2013/518945518945Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up StudyMaria do Sameiro-Faria0Sandra Ribeiro1Elísio Costa2Denisa Mendonça3Laetitia Teixeira4Petronila Rocha-Pereira5João Fernandes6Henrique Nascimento7Michaela Kohlova8Flávio Reis9Leonilde Amado10Elsa Bronze-da-Rocha11Vasco Miranda12Alexandre Quintanilha13Luís Belo14Alice Santos-Silva15Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, PortugalInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalCentro Investigação Ciências Saúde, Universidade Beira Interior, Covilhã, PortugalCentro Investigação Ciências Saúde, Universidade Beira Interior, Covilhã, PortugalNephrocare Portugal, SA-Nephrocare Maia, Maia, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalNephrocare Portugal, SA-Nephrocare Maia, Maia, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalBackground. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significant association of death with these disturbances, by performing a two-year follow-up study. Methods and Results. A large set of data was obtained from 189 HD patients (55.0% male; 66.4 ± 13.9 years old), including hematological data, lipid profile, iron metabolism, nutritional, inflammatory, and endothelial (dys)function markers, and dialysis adequacy. Results. 35 patients (18.5%) died along the follow-up period. Our data showed that the type of vascular access, C-reactive protein (CRP), and triglycerides (TG) are significant predictors of death. The risk of death was higher in patients using central venous catheter (CVC) (Hazard ratio [HR] =3.03, 95% CI = 1.49–6.13), with higher CRP levels (fourth quartile), compared with those with lower levels (first quartile) (HR = 17.3, 95% CI = 2.40–124.9). Patients with higher TG levels (fourth quartile) presented a lower risk of death, compared with those with the lower TG levels (first quartile) (HR = 0.18, 95% CI = 0.05–0.58). Conclusions. The use of CVC, high CRP, and low TG values seem to be independent risk factors for mortality in HD patients.http://dx.doi.org/10.1155/2013/518945
collection DOAJ
language English
format Article
sources DOAJ
author Maria do Sameiro-Faria
Sandra Ribeiro
Elísio Costa
Denisa Mendonça
Laetitia Teixeira
Petronila Rocha-Pereira
João Fernandes
Henrique Nascimento
Michaela Kohlova
Flávio Reis
Leonilde Amado
Elsa Bronze-da-Rocha
Vasco Miranda
Alexandre Quintanilha
Luís Belo
Alice Santos-Silva
spellingShingle Maria do Sameiro-Faria
Sandra Ribeiro
Elísio Costa
Denisa Mendonça
Laetitia Teixeira
Petronila Rocha-Pereira
João Fernandes
Henrique Nascimento
Michaela Kohlova
Flávio Reis
Leonilde Amado
Elsa Bronze-da-Rocha
Vasco Miranda
Alexandre Quintanilha
Luís Belo
Alice Santos-Silva
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
Disease Markers
author_facet Maria do Sameiro-Faria
Sandra Ribeiro
Elísio Costa
Denisa Mendonça
Laetitia Teixeira
Petronila Rocha-Pereira
João Fernandes
Henrique Nascimento
Michaela Kohlova
Flávio Reis
Leonilde Amado
Elsa Bronze-da-Rocha
Vasco Miranda
Alexandre Quintanilha
Luís Belo
Alice Santos-Silva
author_sort Maria do Sameiro-Faria
title Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
title_short Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
title_full Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
title_fullStr Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
title_full_unstemmed Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
title_sort risk factors for mortality in hemodialysis patients: two-year follow-up study
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2013-01-01
description Background. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significant association of death with these disturbances, by performing a two-year follow-up study. Methods and Results. A large set of data was obtained from 189 HD patients (55.0% male; 66.4 ± 13.9 years old), including hematological data, lipid profile, iron metabolism, nutritional, inflammatory, and endothelial (dys)function markers, and dialysis adequacy. Results. 35 patients (18.5%) died along the follow-up period. Our data showed that the type of vascular access, C-reactive protein (CRP), and triglycerides (TG) are significant predictors of death. The risk of death was higher in patients using central venous catheter (CVC) (Hazard ratio [HR] =3.03, 95% CI = 1.49–6.13), with higher CRP levels (fourth quartile), compared with those with lower levels (first quartile) (HR = 17.3, 95% CI = 2.40–124.9). Patients with higher TG levels (fourth quartile) presented a lower risk of death, compared with those with the lower TG levels (first quartile) (HR = 0.18, 95% CI = 0.05–0.58). Conclusions. The use of CVC, high CRP, and low TG values seem to be independent risk factors for mortality in HD patients.
url http://dx.doi.org/10.1155/2013/518945
work_keys_str_mv AT mariadosameirofaria riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT sandraribeiro riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT elisiocosta riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT denisamendonca riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT laetitiateixeira riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT petronilarochapereira riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT joaofernandes riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT henriquenascimento riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT michaelakohlova riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT flavioreis riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT leonildeamado riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT elsabronzedarocha riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT vascomiranda riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT alexandrequintanilha riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT luisbelo riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
AT alicesantossilva riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy
_version_ 1725580583555301376